PRFX
vs
S&P 500
PRFX
S&P 500
Over the past 12 months, PRFX has underperformed S&P 500, delivering a return of -78% compared to the S&P 500's +29% growth.
Stocks Performance
PRFX vs S&P 500
Performance Gap
PRFX vs S&P 500
Performance By Year
PRFX vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
PainReform Ltd
Glance View
PainReform Ltd. operates as a pharmaceutical company. The Company’s main activity is to develop reformulation of established pain therapeutics. PainReform Ltd provides technology, which is dedicated to prolong and enhance efficacy, minimize adverse effects and increase patients convenience as well as faster return of motor function.